Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
54.65
+9.47 (20.96%)
At close: Mar 6, 2026

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
35,59723,5853,3954,78510,245-
Market Cap Growth
1066.58%594.71%-29.05%-53.29%--
Enterprise Value
35,74123,7293,5624,68210,003-
Last Close Price
54.6535.308.5011.9825.65-
PE Ratio
114.21122.3795.11---
PS Ratio
23.2015.373.256.0616.97-
PB Ratio
--3.805.507.87-
P/TBV Ratio
--3.925.738.12-
P/FCF Ratio
--18.32---
P/OCF Ratio
--15.10---
EV/Sales Ratio
23.2915.473.415.9316.57-
EV/EBITDA Ratio
98.0865.1211.58---
EV/EBIT Ratio
170.31113.0822.29---
EV/FCF Ratio
--19.23---
Debt / Equity Ratio
--0.680.690.360.07
Debt / EBITDA Ratio
--1.80---
Debt / FCF Ratio
--3.28---
Net Debt / Equity Ratio
--0.190.14-0.20-0.39
Net Debt / EBITDA Ratio
--0.55-0.710.491.16
Net Debt / FCF Ratio
--0.91-0.540.420.86
Asset Turnover
--0.400.270.210.15
Inventory Turnover
--26.8012.256.096.11
Quick Ratio
--1.221.011.251.55
Current Ratio
--1.531.251.521.96
Return on Equity (ROE)
--4.12%-39.45%-50.12%-40.27%
Return on Assets (ROA)
--3.86%-6.94%-14.81%-14.02%
Return on Invested Capital (ROIC)
33.93%34.82%12.36%-31.99%-71.53%-76.89%
Return on Capital Employed (ROCE)
--8.00%-15.60%-27.60%-28.00%
Earnings Yield
0.54%0.82%1.05%-8.82%-6.64%-
FCF Yield
--5.46%-4.68%-6.00%-
Buyback Yield / Dilution
0.31%-1.20%0.08%-4.54%-5.13%-180.82%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.